Cellutions is developing proprietary medical devices and procedures to treat cellulite, a condition that affects 90% of post-adolescent females. The company is developing a proprietary technology/procedure to be performed in an outpatient setting as a minimally invasive ‘lunchtime' treatment.
The company has raised $13.6 million in Series A and B financings, which is being used for proof of concept in a human feasibility study.
2905 Premiere Parkway, Suite 150
Duluth, GA 30097